All Posts

What’s New in Crohn’s Disease Care? ACG Publishes Updated Guidelines   The American Journal of Gastroenterology (AJG) published in June 2025 the updated guideline on Crohn’s disease (CD), issued by the American College of Gastroenterology (ACG). This revision addresses the global increase in the incidence and prevalence of CD, along with the substantial growth in available therapeutic options since the previous guideline was released in 2018. The updated guideline aims to rev

Expanding into LATAM? Here’s What You Should Know.   At PRS, one of the most rewarding aspects of our work is seeing global clinical trials thrive in Latin America, driven by local teams, solid regulatory frameworks, and a deep commitment to patient-centered execution. These successes aren’t accidental — they’re the result of thoughtful planning, regulatory insight, and hands-on execution. If your company is planning to expand into LATAM, we’d be glad to share what we’ve lear

Redefining Success in Clinical Research—One Trial at a Time Success in clinical trials isn’t just about hitting milestones—it's about exceeding expectations while maintaining scientific and ethical integrity.   Behind every successful clinical trial is a team that believes in precision, perseverance, and patient-centered progress.

Rescue. Realign. Relaunch. Supporting Your Trial When It Matters Most. Clinical trials often don’t proceed as planned. Delays, miscommunication, and local regulatory hurdles can slow down even the most promising studies, and timelines don’t wait.   That’s where PRS comes in. We’re a Chile-based CRO with deep regional expertise and a hands-on, flexible approach. Our team is ready to step in when you need local support to keep things moving — or to get things back on track.

The Modernization Act 2.0 authorizes the use of certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug. The bill also removes the requirement to use animal studies as part of the process to obtain a license for a biological product that is biosimilar or interchangeable with another biological product. These shifts open new doors

Why Chile Continues to Attract Global Sponsors Chile offers one of the most stable and efficient clinical research environments in LATAM — combining fast regulatory timelines, modern infrastructure, and motivated patient communities. At PRS, we work hand-in-hand with experienced Chilean investigators, top-performing sites, and accredited institutions. They are not only ICH/GCP-compliant and internationally trained but also fully aligned with evolving global standards and inno

Redefining Success in Clinical Research—One Trial at a Time   From protocol submission to last-patient-last-visit, every phase matters. Whether you’re planning, recruiting, or closing out — we’re ready to help. At PRS, we tailor our support to meet your trial’s needs — with agility, insight, and proven local execution. If LATAM’s on your radar, we’re happy to share what works — and what to avoid.   Follow us on:   https://lnkd.in/ecQCV8Qi